loader2
Partner With Us NRI

Company details

15.40
16.10
11.40
24.95
6M Return 10.32%
1Y Return 25.20%
Mkt Cap.(Cr) 8.41
Volume 9
Div Yield 0.00%
OI
-
OI Chg %
-
Volume 9

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 12.02 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 30,916.98 -44,588.21
LAST 3M 79,590.49 -44,523.79
LAST 6M 143,408.31 -191,400.91
LAST 12M 204,102.65 -163,801.53

Information

  • About Company
  • Company Info
  • Listing Info
0
64.14%
4.0678
-13.3%
-41.62%
Description
  • Incorporated on 31st March 1980 as Private Ltd. Co. and converted into a Public Ltd. Co. on 14th August 1993. Promoted by Dr.P.K.Desai. The Company is engaged in manufacturing a wide range of microbiological, immunological and bio-chemical diognostic reagents, plastic accessories and allied products in its plant at Udhna. The Company completed expansion-cum-modernisation and mechanisation of packing activities at Udhna. Acquiring three plots of land at GIDC Sachin admeasuring 33,897 sq. mtrs. which is situated near the State Highway and National Highway No.8.This project was finance by way of internal accruals of Rs.31.62 lakhs and balance from Term Loans of Rs.30 lakhs. The Company entered into the technical arrangement with Bioprobe Netherland, Path U.S.A. Dynajen U.S.A. for manufacturing HIV Dipsticks, Myco-dot, Monoclonal anitbodies. Company launched several new products developed by its R & D Center such as One Step Lateral Chromotography Based Assay for monitoring of pregnancy and Hepatitis to be marketed under the brand name of CRYSTAL as well as HIV Flow Through. The continuation distributorship arrangements with Murex Biotech UK Ltd which is now subsidiary of Abbott Diagnostics USA will also generate substantial business from the nitche market of the Blood Bank Segment.

Read More

No Data Found

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 524727
NSE Code :
Book Closure Date (Month) : Sep
BSE Group : X
ISIN : INE004E01016

ICICIdirect Span Divergent Ltd FAQ

You can buy Span Divergent Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Span Divergent Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 16, 2022 04:00 PM the closing price of Span Divergent Ltd was ₹ 15.40.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 16, 2022 04:00 PM, the market cap of Span Divergent Ltd stood at ₹ 8.41.
The latest PE ratio of Span Divergent Ltd as of May 16, 2022 04:00 PM is 0
The latest PB ratio of Span Divergent Ltd as of May 16, 2022 04:00 PM is 0.26
The 52-week high of Span Divergent Ltd is ₹ 24.95 while the 52-week low is ₹ 11.40 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE